Your browser doesn't support javascript.
loading
Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) Trial.
Koutras, Angelos; Zagouri, Flora; Koliou, Georgia-Angeliki; Psoma, Elizabeth; Chryssogonidis, Ioannis; Lazaridis, Georgios; Tryfonopoulos, Dimitrios; Kotsakis, Athanasios; Res, Eleni; Kentepozidis, Nikolaos K; Razis, Evangelia; Psyrri, Amanda; Koumakis, Georgios; Kalofonos, Haralabos P; Dimopoulos, Meletios A; Fountzilas, George.
Afiliação
  • Koutras A; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece. angkoutr@otenet.gr.
  • Zagouri F; Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
  • Psoma E; Department of Radiology, AHEPA Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Chryssogonidis I; Department of Radiology, AHEPA Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Lazaridis G; Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Tryfonopoulos D; Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece.
  • Kotsakis A; Department of Medical Oncology, University General Hospital of Heraklion Crete, Heraklion, Greece.
  • Res E; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece.
  • Kentepozidis NK; Department of Medical Oncology, 251 Airforce General Hospital, Athens, Greece.
  • Razis E; Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece.
  • Psyrri A; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Koumakis G; Second Department of Internal Medicine, Agios Savvas Cancer Hospital, Athens, Greece.
  • Kalofonos HP; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece.
  • Dimopoulos MA; Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Fountzilas G; Aristotle University of Thessaloniki, Thessaloniki, Greece.
Br J Cancer ; 123(3): 355-361, 2020 08.
Article em En | MEDLINE | ID: mdl-32488135
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Taxoides Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Grécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Taxoides Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Grécia